Donut Hole Discounts Would Cost Medicare $17.4 Bil.; AARP Wants Phase Out
Executive Summary
The pharmaceutical industry proposal to provide 50 percent discounts on the price of branded drugs for Medicare Part D beneficiaries in the donut hole would wind up costing the federal government $17.4 billion over 10 years, according to estimates by the Congressional Budget Office and the Joint Committee on Taxation released Sept. 16
You may also be interested in...
Part D Gap Rebates Boost Medicare Rx Spending To 9% Gain In 2010
Drug spending by the Medicare program increased more than by Medicaid or by private payers in 2010, according to an analysis by CMS; expenditures in Medicaid and by private insurance were level with the previous year and consumer out-of-pocket spending declined. Total drug spending across-the-board rose 1.2% to $259 billion.
Pharma's Reform Bounce: How Big A Boost Will $80 Bil. Buy
The introduction of the Senate Finance Committee's health care proposal turns the focus from what the pharmaceutical industry will contribute to reform efforts toward what manufacturers stand to gain
Pharma's Reform Bounce: How Big A Boost Will $80 Bil. Buy
The introduction of the Senate Finance Committee's health care proposal turns the focus from what the pharmaceutical industry will contribute to reform efforts toward what manufacturers stand to gain